These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15664862)

  • 1. 1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agents.
    Coppola GM; Damon RE; Eskesen JB; France DS; Paterniti JR
    Bioorg Med Chem Lett; 2005 Feb; 15(3):809-12. PubMed ID: 15664862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents.
    Coppola GM; Damon RE; Eskesen JB; France DS; Paterniti JR
    Bioorg Med Chem Lett; 2006 Jan; 16(1):113-7. PubMed ID: 16216504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiourea-based gemfibrozil analogues as HDL-elevating agents.
    Coppola GM; Damon RE; Eskesen JB; France DS; Paterniti JR
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2439-42. PubMed ID: 12161152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y; Yan B; Fu M; Xu Y; Tian Y
    Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Acyl-, 3-acyl- and 1,3-diacyl-3-furfuryl-1-phenylthioureas with platelet antiaggregating and other activities.
    Ranise A; Bondavalli F; Bruno O; Schenone S; Donnoli D; Parrillo C; Cenicola ML; Rossi F
    Farmaco; 1991 Oct; 46(10):1203-16. PubMed ID: 1687723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.
    Muccioli GG; Wouters J; Scriba GK; Poppitz W; Poupaert JH; Lambert DM
    J Med Chem; 2005 Nov; 48(23):7486-90. PubMed ID: 16279809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
    Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
    Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,3-disubstituted 1-acyl-1-phenylthioureas with platelet antiaggregating and other activities.
    Ranise A; Bondavalli F; Bruno O; Schenone S; Losasso C; Costantino M; Cenicola ML; Donnoli D; Marmo E
    Farmaco; 1991 Feb; 46(2):317-38. PubMed ID: 1677578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs.
    Idrees GA; Aly OM; Abuo-Rahma Gel-D; Radwan MF
    Eur J Med Chem; 2009 Oct; 44(10):3973-80. PubMed ID: 19450906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
    Tian L; Wu J; Fu M; Xu Y; Jia L
    Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis, structure and cytokinin-like activity of N-alkyl- and phenyl-N' -halogenophenylthioureas].
    Vassilev GN; Jonova PA
    Pharmazie; 1978 May; 33(5):270-3. PubMed ID: 674334
    [No Abstract]   [Full Text] [Related]  

  • 13. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S; Liu T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
    Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
    Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of prebeta1 HDL and alphaHDL in type II diabetic patients.
    Chétiveaux M; Lalanne F; Lambert G; Zair Y; Ouguerram K; Krempf M
    Eur J Clin Invest; 2006 Jan; 36(1):29-34. PubMed ID: 16403007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
    Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
    Terra SG; Francone OL; Contant CF; Gao X; Lewin AJ; Nguyen TT
    Am J Cardiol; 2008 Aug; 102(4):434-9. PubMed ID: 18678301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms.
    Jia L; Bai H; Fu M; Xu Y; Yang Y; Long S
    Clin Chim Acta; 2005 Oct; 360(1-2):37-45. PubMed ID: 15925353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.